The author
Christian Meyer, Chief Medical Officer, MD, PhD.
Experienced biotech executive. Interested in all aspects of clinical research leadership and management.-
Blog Stats
- 5,057 hits
-
My most recent pieces
- “Clinical Project Leadership versus Clinical Project Management”
- How to allow researchers to continue exploitation of clinical data in a close down situation
- How to rise clinical development from lethargy
- 10 basic operational challenges in todays changing landscape
- The value of creating standards
- Who’s Afraid of Risk-Based Monitoring? – by GUEST AUTHOR
- Can we stop the spiral of clinical trial costs?
- Decline in clinical research studies stabilised – but can it increase again?
- “…wishing for the nightmare of a recurrence…”
- Controversies in the world of clinical trials
- “…making a dent in the universe…”
- People, processes – processes, people: Inseparable entities in industry sponsored clinical research
- “The seven habits…..” – Clinical Research Leadership principles
- EMA – a role model for respectful harmonization efforts?
- Is clinical quality assurance in early phase trials really important?
Categories
Archives
Tags
Clinical monitoring Clinical research Clinical trial Contract Research Organization Execution Risk FDA GCP Good Clinical Practice Histogram Innovation Leadership Management Oversight Project Management Project team Quality assurance Quality Management Site Performance Site selection Start-Up Strategy Trial feasibility Trial Start-Up Tips Vendor Contracting Vendor Identification Vendor Selection Virtual Biotech Virtual business- Blogposts in Danish Clinical Trial Methodology Closing down a biotech company Electronic systems Enrollment performance Guest Authors Leadership Challenges Outsourcing Strategy Rescue Study Syndrome Risk-Based Monitoring Strategies Risk-Based Oversight of Clinical Trials Study Start-Up Trial feasibility Uncategorized Vendor oversight Virtual Biotech
Tag Archives: Contract Research Organization
What is the “right” outsourcing strategy?
The question of the “right” outsourcing strategy for a given company or project easily reaches the proportions of a religious debate between the fanatical supporters of one approach with equally fanatic opponents. The only fundamental point of view everybody with … Continue reading
Negative GCP inspections (The Neurosearch Case) – does it impact project value?
One of the big challenges in a small biotech company – when starting a clinical research unit from scratch with your first clinical trials – is finding the right balance with your quality assurance system. You have no system established … Continue reading
Prevention of the “Rescue Syndrome” – II
The mindset in a small biotech company tends to be “we are small and we only have very little resources”. Maybe the resources are in fact too scarce to manage the project properly, but then the expectations and the budgeting … Continue reading
